Antioxidant
and Hepatoprotective properties of Terminalia arjuna
Bark on Isoniazid Induced Toxicity in Albino rats
P. Doorika and T. Ananthi*
ABSTRACT:
The aqueous extract of Terminalia arjuna bark was
investigated for its hepatoprotective effect against isoniazid induced acute liver damage on albino rats. Isoniazid (100mg/kg) significantly elevated the serum
levels of biochemical markers like SGPT, SGOT, ALP, ACP, Bilirubin,
Protein and depleted antioxidant enzymes GSH and SOD
upon administration of Isoniazid (100mg/kg) to albino
rats. This indicated that there the aqeous extract of
bark of Terminalia arjuna
at 200mg/kg dose significantly reduced the elevated levels of biochemical
markers mentioned above. Test extract treatment also increased the level of SOD
and GSH. These results suggest that aqueous extract of Terminalia arjuna may have
the potential therapeutic value in the treatment of Isoniazid
induced hepatic damage and some liver diseases. Hepatoprotective
activity of the study plant may be attributed to the anti-oxidant principles in
it.
KEY WORDS: Terminalia arjuna,
Isoniazid, Hepatoprotective,
antioxidant
INTRODUCTION:
The
liver is largest glandular organ in the body and weight 1.5kg making up about
2-3% of the total body weight. It is responsible for detoxifying the poisonous
substances in the body by transforming and removing toxins and wastes. The
liver serves a variety of functions. The most crucial is its role in the body’s
metabolism. There is no organ is more important to healthy metabolism than the
liver in many ways (Robbins et al.,
2003).
Liver
disease is a collective term for a whole group of problems that afflict the
tissues, structures and cells of the human liver. The liver performs a
multitude of important functions, so there’s plenty of opportunity for
something to go wrong. One of the most common causes of liver disease is
inflammation, which often results from abuse of alcohol, poor diet or even
malnutrition (Arias et al., 1989).
Drug
induced liver injury is the major health problem that challenges not only care
health professional but also the pharmaceutical industry and drug regulatory
agencies. According to the United States Acute Liver Failure Study Group, drug
induced liver injury accounts for more than 50% of acute liver failure,
including hepatotoxicity caused by over dose of
acetaminophen (39%) and idiosyncratic liver injury triggered by other drugs (Micheale and Cynthiya, 2006) .
Medicinal
herbs are significant source of pharmaceutical drugs. Latest trends have shown
increasing demand of phyto drugs and some medicinal
herbs have proven hepato protective potential.
Medicinal herbs and extracts prepared from them are widely used in the
treatment of liver diseases like hepatitis, cirrhosis, and loss of appetite (Nadkarni and Nadkarni, 1954).
Terminalia arjuna is a deciduous and ever green tree, standing 20-30m
above ground level. It belongs to Combretaceae family
(Chopra and Ghosh, 1929). It is found in Uttar Pradesh, South Bihar,
Madhya Pradesh, Delhi and Deccan region near ponds and livers. Ancient Indian
physicians used the powdered tree bark of Terminalia arjuna for
alleviating “Hritshool” (angina) and other
cardiovascular conditions. Its stem bark possesses glycosides, large quantities
of flavonoids,
tannins and minerals. Flavonoids have been detected
to exert antioxidant, anti inflammatory and lipid lowering effects while
glycosides are cardiotonic, thus making Terminalia arjuna
unique amongst currently used medicinal plants.
MATERIALS AND
METHODS:
Collection of plant materials:
The
plant material Terminalia arjuna
was collected from Trichy district which was
carefully identified with the help of regional floras.
Extraction of plant material:
Aqueous
extract was prepared according to the methodology of Indian pharmacopoeia. The
shady dried plant materials were subjected to pulverization to get coarse
powder. The coarse powder material was subjected to sox let extraction
separately and successively with distilled water. These extract was
concentrated to dryness in flash evaporator under reduce pressure and
controlled temperature (40 – 50o C). The aqueous extract put in air
tight containers stored in refrigeration.
Phytochemical analysis:
Phytochemical
analysis for major phytoconstituents of the plant
extract was undertaken using standard methods .The plant was screened for the
presence of biologically active compounds like sugars, amino acids, proteins,
phenols, terpenoids, etc.
Collection of animal species:
The
healthy young adult female rats (120-200gm sex) were kept separately in
individual polypropylene cages with stainless steel hopper. The females was nulliparous and non pregnant, at the commencement of the
study, the weight of the animals were minimal and not exceed ± 20% of the mean
weight.
Experimental hepatotoxicity:
Isoniazid
(100 mg/kg body weight) solution was prepared separately in sterile distilled
water. Rats were treated with Isoniazid, administered
for 10 days by IP route (Jing et al.,
2004).
In
order to the study the effect of aqueous extract of bark of Terminalia arjuna in rat 200mg/kg.bwt (Gupta et al., 2005). Rats were divided into
four groups.
Experimental design:
Albino
rats of either sex between 120-200g were randomly assigned into 4 groups of 6
animals each. Group-I (Negative control) received 1ml/kg normal saline,
Group-II (Isoniazid 100mg/kg), Group-III (200mg/kg aqeous extract only) and Group-IV (treated 200mg/kg aqeous
extract after induction with Isoniazid) were treated with respective treatments for 20
days. The blood samples were drawn from all the animals by puncturing
retro-orbital plexus on 20th day of the treatment. The blood samples
were centrifuged immediately to get clear serum and subjected for estimation of
various biochemical parameters namely SGPT (Reitman
and Frankel, 1957), SGOT (King and King, 1954), ALP, ACP (Committee on enzymes
of the Scandinavian society), and Serum protein (Lowry et al., 1951), Serum Bilirubin (Malloy
and Evelyn, 1937), SOD (Kakkar and Viswanathan, 1998) GSH (Griffith1980).
Statistical Analysis:
The
value are reported are means + SD (n=6). Experimental
results were statistically analyzed using the variance (ANOVA) by student t’
test.
RESULTS AND
DISCUSSION:
Preliminary phytochemical Screening:
The
plant extract of Terminalia arjuna were
screened for the presence of biologically active compounds like steroids,
tannins, phenolics compound, quinone,
terpinoids, sugar, alkaloids and flavonoids
(Table 1).
Table I
: Preliminary phytochemical investigation in the aqueous extract of bark
of Terminalia arjuna
Phytochemical compound |
Result of qualitative test |
Sugar |
+ |
Terpinoids |
+ |
Alkaloids |
+ |
Phenolic compounds |
+ |
Tannins |
+ |
Flavanoids |
+ |
Volatile oil |
- |
Quinones |
+ |
Steroids |
+ |
Coumarins |
- |
+ indicates presence; -
indicates absence
Serum Protein:
A
significant increase (p<0.01) in serum protein level was noted in group III
when compared to Group II. Also there was a significant increase (p<0.05) in
serum protein level in group IV when compared to Group II. Thus the restoration
of the level of serum and tissue protein after the administration of Terminalia arjuna
confirmed the hepatoprotective nature of it (Table
II).
Previous
studies on the hepatoprotective effect of Terminalia chebula extract against antipyretic drug
induced hepatotoxicity proved that the extract
exhibited hepatoprotective nature by restoring the
total serum protein level (Gujarti et al., 2006).
Serum Bilirubin:
A
significant increase (p<0.05) in serum bilirubin
levels in Group II was observed when compared to Group I. A significant
decrease (p<0.05) in serum bilirubin level was
noted in group IV when compared to Group II. But there was no significant
change when Group I was compared with Group IV (Table II).
Bilirubin
concentrations have been used to evaluate chemically induced hepatic injury
(Giuseppe cooper et al., 2004).
Treatment with Terminalia arjuna
extract reduced the elevated level of bilirubin.
This is probably due to the presence of highest content of phenolic
derivatives that exert bile flow and liver protection. Thus Terminalia arjuna has cholertic activity.
Table II
: Estimation of Serum Proteins and Bilirubin
S. No |
Groups |
Proteins (mg/g) |
Bilirubin (µm/mg) |
1. |
Group I |
0.91±0.4 |
1.59±0.91 |
2. |
Group II |
0.61±0.3 |
4.23±1.24 |
3. |
Group III |
0.79±0.9 |
1.88±0.45 |
4. |
Group IV |
0.88±0.1 |
2.02±1.31 |
Values are means ± SD from 6
rats in each observation.
*<0.05; **<0.01; as
compared with Group II. +<0.05,
as compared with normal group.
Serum ALP:
Serum
level of ALP were increased significantly in group II rat (p<0.05) when
compared to Group I. A significant decrease in ALP levels were observed in
Group III (p<0.01) and Group IV (p<0.05). (Table III). Elevated levels of
serum and tissue alkaline phosphates are indicative of cellular leakage and
loss of functional integrity of cell membrane in liver cells (Sethu mathavan et al., 2007). Damage to liver cells
cause leakage of cellular enzymes into serum.
In
the present study the ALP levels returned to normal by administration of Terminalia arjuna
with healing of parenchyma and regeneration of hepatocytes.
Previous study on Solanum nigrum
reduced the elevated level of ALP in CCl4 included hepatotoxicity (Ruiz et al., 2008).
Serum ACP:
A
significant increase (p<0.05) in the levels of serum acid phosphatase level was observed. A significant decrease
(p<0.01) in serum acid phosphatase level was seen
in Group III when compared to Group II. Similarly, a significant decrease
(p<0.05) in ACP levels was noted in Group IV when compared to Group II. But
no significant changes were observed between Group I and Group IV (Table III).
The
abnormal higher level of marker enzymes such as ACP and bilirubin
in the serum of CCl4 treated rat indicate damage to hepatic cells (Venukumar and Latha, 2002).In the
present study, treatment with Terminalia arjuna extract reduced the elevated levels of ACP . Glycosmis arborea
extract overcome the toxic effects of hepatotoxic agents
by the lowering the levels of ACP (Gomes et
al., 2003).
Table III
: Estimation of Serum ALP and ACP
S. No |
Groups |
Serum ALP (KA Units) |
Serum ACP(KA Units) |
1. |
Group I |
13.96±0.78 |
5.68±0.29 |
2. |
Group II |
22.92±0.16 |
11.82±0.31 |
3. |
Group III |
15.28±0.98 |
5.93±0.11 |
4. |
Group IV |
19.96±0.21 |
9.86±1.05 |
Values
are mean ± SD from 6 rats in each observation. *<0.05; **<0.01; as
compared with Group II.
+<0.05, as compared with normal group
SGOT:
A
significant increase in SGOT activity (p<0.05) was noted in Group II when
compared to Group I. A significant decrease (P<0.05) in serum SGOT level was
observed in Group III when compared to Group II. Also a significant decrease
(P<0.05) in serum SGOT level in Group IV was noted when compared to Group II
(Table IV).
The
Isoniazid has got hepatotoxic
potentical (Yew et
al., 2006). Isoniazid metabolite hydrazine plays
an important role in inducing hepatotoxicity (Al-Howiriny et al.,
2004). Isoniazid hepatotoxicity
results in hepatocellular damage, thus variety of
enzymes normally located in the cytosol are released
into blood stream. The elevated level of SGOT due to Isoniazid
hepatotoxicity was normalized by treatment with Terminalia arjuna.
This is probably because of free radical scavenging activity of flavonoids and polyphenols
present in Terminalia arjuna.
SGPT:
An
increased level of SGPT (p<0.05) was found in Group II rat when compared
with Group I. A significant decrease (p<0.01) in serum SGPT level was noted
in Group III when compared to Group II. Also there was a significant decrease
(p<0.05) in serum SGPT level in Group IV when compared to Group II. But
there was no significant change between Group I and Group IV (Table IV).
The
normalization of plasma
alanine amino transferase
(SGPT) has been proved to be a strategy for preventing the development of hepatocellular carcinoma in hepatitis C virus (HCV)
infection. In the present study treatment with Terminalia arjuna extract
normalized the elevated SGPT levels. Osthole, a
simple coumarin caused strong reduction of plasma
SGPT and exhibited hepatoprotective nature (Okamoto et al., 2005).
Table IV: Estimation of
Serum SGOT and SGPT
S. No |
Groups |
Serum SGOT (IU/L) |
Serum SGPT (IU/L) |
1. |
Group I |
16.28±2.09 |
6.96±0.75 |
2. |
Group II |
32.54±1.28 |
12.33±0.58 |
3. |
Group III |
17.29±1.33 |
6.99±0.55 |
4. |
Group IV |
19.36±2.92 |
7.38±1.29 |
Values are mean ± SD from 6
rats in each observation. *<0.05; **<0.01; as compared with Group II.
+<0.05, as compared with normal group.
SOD:
There
was a significant decrease (p<0.05) in SOD levels in Group II when compared
to Group I. A significant increase (p<0.01) in serum SOD level was noted in
Group III when compared to Group II. Also there was a significant decrease
(p<0.05) in serum level was noted in Group IV when compared to group II. But
there was no significant change between Group I and Group IV (Table V).
SOD
is very effective antioxidant enzyme and responsible for catalytic disputation
of highly reactive and potentially toxic superoxide radicals to H2O2.The H2O2
is further metabolized either by catalase or peroxidase. The non enzymatic antioxidants such as GSH, Vit.E and Vit.C act as scavengers
(Foyer et al., 1993).
GSH:
There
was a significant decrease (p<0.05) in level of Reduced Glutathione in Group
II when compared to Group I. A significant increase (p<0.01) in level of
Reduced Glutathione was noted in Group III when compared to Group II. Also
there was a significant increase (p<0.05) in level of reduced glutathione in
Group IV. When compared to Group II. But there was no significant change between
Group I and Group IV.
GSH
in the cytosolic pool consists of 85% hepatocellular GSH and 15% mitochondrial GSH. Hepatic GSH
depletion or even extra hepatic GSH depletion can provide useful information on
the protective role of GSH against toxic foreign compounds. Thus GSH, be
regarded as an endogenous protective agent against drugs (Chattopadhyay,
1992).
Table V
: Estimation of Serum SOD and GSH
S. No |
Groups |
Serum SOD (mg/dl) |
Serum GSH (mg/dl) |
1. |
Group I |
5.33±0.97 |
4.38±0.22 |
2. |
Group II |
4.14±0.28 |
2.23±0.24 |
3. |
Group III |
5.30±0.21 |
4.78±0.45 |
4. |
Group IV |
5.16±2.01 |
5.15±1.31 |
Values are mean ± SD from 6
rats in each observation. *<0.05; **<0.01; as compared with Group II.
+<0.05, as compared with normal group.
CONCLUSION:
The
present findings demonstrated the hepatoprotective
and antioxidant effect of Terminalia arjuna aqueous bark extract
against Isoniazid induced hepatotoxicity.
According to traditional indigenous medicinal systems of India this plant has
got several medicinal effects without producing any severe side effects. This
plant could be very well used as hepato protectant. However this is only a tentative research and
more work is to be done to identify the extract phytochemical responsible for
this curative effect.
REFERENCES:
1.
Al-Howiriny TA, Al-Sohaibani MO,
Al-Said MS, Al-Yahya MA., Tahir
KH. and Rafatullah S. Hepatoprotective
properties of Commiphora opobalsamum
(“Balessan”), a traditional medicinal plant of Saudi
Arabia. J. Drugs-Exp-Clin-Res.,
30 (5-6); 2004: 213-20.
2.
Arias PS, Bessey AA, Lowery DM and Brock M. Lipid peroxidation
Biochemistry measurement and significance in liver cell injury. Indian. J. Exp. Biol., 45; 1989: 87-89.
3.
Chattopadhyay RR, Sarkar SK, Ganguly S, Medda C and Basu TK. Hepatoprotective
activity of Ocimum sanctum leaf extract against
paracetamol induced hepatic damage in rats. J. Ethnopharmacol., 24; 1992:163.
4.
Chopra RN and Ghosh S. Terminalia arjuna: its chemistry,
pharmacology and therapeutic action. Indian
Medical Gazette, 64; 1929: 70-73.
5.
Foyer CH, Alscher RG, Hess JL. Antioxidants
in higher plants. Boca Raton CRC Press 1993; 31‐58.
6.
Gilan S, Deduce C., Singh J, Hussain
Janbaz MS. Evaluation of the protection potential of Agave Americana extract on acetaminophen
induced liver injury.2002.
7.
Giuseppe Cooper
JR, Bloom F.E. and
Roth R.H.. Hepatopharmacological study of Agave Americana linn
in thioacetamide induced liver damage in rats. Indian Medicinal Plants. 2004: 10-12.
8.
Gomes M, Das P, Besra SE, Chakravorty A, Das B, Ganguly DK and Vedasiromoni
JR. Glycosmis arborea
extract as a hepatoprotective agent. Phytother. Res., 17(5); 2003: 571-74.
9.
Griffith O.
Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinyl pyridine. Anal Biochem., 106; 1980: 207.
10.
Gujarti S, Nigerians K, Pandima Devi
M, Sreepriya K and. Balakrishnan
K. Protective activity Tylophora indica
extract on paracetamol induced liver damage. I. J. of Ethnopharmacology, 3; 2006:
95-100.
11.
Gupta RK, Kesari AN, Murthy PS, Chandran R,
Tandon V and Wata G. Antihyperglycemic
activity of Ficus deltoidea ethanolic extract in normal rats. J. Ethnopharmacol., 99(1); 2005: 75-81.
12.
Jing TUE, Ren-xiu ENG, Jing YANG, Rui.
CYP2E1 isoniazid induced hepatotoxicity
in rats. Acta Pharmacol Sin.,
25(5); 2004: 699-704.
13.
Kakkar P, Das B, Viswanathan
PN. A modified spectrophoto‐ metric assay of superoxide dismutase. Indian J. Biochem. Biophys
21; 1998: 130‐132.
14.
King PRN and King
EJJ. Estimation of plasma phosphatase by
determination of hydrolyzed phenol with aminopyrines.
J. Clin. Pathol.,
7; 1954: 332.
15.
Lowry OH, Rosebrough NJ, Farr A and Randall
RJ. Protein measurement with the Folin phenol
reagent, J. Biol
Che.,193;1951:265.
16.
Malloy HT, Evelyn
KA. The determination of
bilirubin with the photometric
colorimeter. J. Biol. Chem., 119;
1937: 481.
17.
Micheale P, Cynthiya Ju. Mechanism of Drug induced liver injury. The AAPS Journal.,
1; 2006: 48-54.
18. Nadkarni AK, Nadkarni KM. Indian Materia Medica. First ed. Popular Book Deport. Bomaby India, 1954:1198.
19.
Okamoto Nadro,
Rall,
Eteng Mu, Hepatoprotective
effect of Balamites agyptiaca against the liver damage. I. J. of Pharmacol.
Sci, 30; 2005: 148-151.
20.
Reitman S, Frankel S. Colorimetric method for the
determination of serum glutamatic oxaloacetic
acid and glutamic pyruvic transaminases. Am. J.
Clin. Pathol., 28; 1957:56.
21.
Robbins J, Fleurentin C, Hefler A. Hepatoprotective properties of crepisrueppelli and anisotes Trisules. Journal
of ethanopharmacology., 76; 2003: 105-111.
22.
Ruiz-Term F, Merdrano-Martinez A and Navaroo Ocana. Antioxidant and free radical scavenging activities
of plant extract used in traditional medicine in mexico. African
Journal of Biotechnology. 7(12): 2008; 1886.
23.
Sethumadhavan, S., Theruvathil, S., Rangaswamy, A., Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced
toxicity in experimental rats. European
J. Pharmacol. Xx; 2007: XXX-XXX.
24.
The committee on enzymes of the Scandinavian society for clinical
chemistry and clinical Physiology, Recommended method for determination of fourenzymes in blood, J
Clin. Lab. Invest. 33; 1974: 291-98.
25.
Venukumar MR. and Latha MS. Antioxidant
activity of Ballota glandulosissima
in CCl4 induced hepatopathy in rats. I. J. of Clin. Biochemi.,
17; 2002: 80-87.
26.
Yew AH, Gillani AH, Janbaz KH. Protective effect of Artemisia scoparia extract against carbon
tetra chloride induced hepatotoxicity. Gen Pharmacol., 24(6);
2006:455-58.
Received on 30.12.2011 Accepted on 10.01.2012
© Asian Pharma
Press All Right Reserved
Asian J. Pharm. Tech. 2(1): Jan.-Mar. 2012; Page 15-18